German ministry will not regulate care home reimbursement
This article was originally published in Clinica
It is the job of the self-governing bodies of the health service to determine what items may be reimbursed as medical aids in care homes, and not the German ministry of health's (BMG) responsibility, says Ingeborg Lutter, deputy director of the department for nursing care at the BMG. Speaking at a MedInform conference, held under the auspices of the medical device industry association (BVMed), on the reimbursement of medical aids last week in Cologne, Ms Lutter sought to clarify an ongoing dispute between the statutory health insurance funds, patients and care homes.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.